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Abstract
Background: Poor ovarian reserve and a high rate of pregnancy failure associated
with low quality and quantity of oocytes are observed in poor responders to in vitro
fertilization.
Objective: To assess the effect of age, body mass index (BMI), endometriosis, and
history of ovarian surgery on ovarian reserve in a group of poor responders.
Materials and Methods: In this cross-sectional study 749 women who referred to
Yasmin Clinic of Dr. Cipto Mangunkusumo National General Hospital from January
2013 to June 2017 were enrolled. Two definitions of poor responders and Poseidon
criteria and consecutive sampling techniques were used. Participants were divided
into good and poor responder groups based on the ovarian reserve test; participant
with oocyte ≤ 3 was classified as a poor responder. Based on this, 188 participants with
nine (4-47) oocytes were included in the poor responder group. While, good responder
comprised of two (0-3) oocytes.
Results: Age and anti-Mullerian hormone level (AMH) were significantly associated
with ovarian reserve in the poor-responder group (p < 0.001). However, in multivariate
analyses, age was the only significant predictor of ovarian response in the poor-
responder group (p = 0.004). While endometriosis was the significant predictor of
Poseidon groups 1 and 4, surgical history was the significant predictor of Poseidon
groups 2 and 3. Meanwhile, an increase in BMI decreased the risk of classification
under Poseidon group 3.
Conclusion: Age, AMH, BMI, endometriosis, and history of ovarian surgery affected the
risk of classification of the Poseidon group.
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1. Introduction
Infertility are generally classified into good and
poor responder. Assisted reproductive technology
(ART) is a medical procedure used to treat infertility
by directly manipulating oocytes outside the body.
One of the most common types of ART is in
vitro fertilization (IVF) (1). Approximately 9-24% of
women are poor responders, and this number
has increased in the last decade (2). Some study
have shown that poor responders are at risk
of developing pregnancy complications, such as
hypertension and preeclampsia, due to low-quality
embryo (3, 4). About 56% of sub fertile couples
worldwide undergo IVF, with a success rate of 30-
40% (5). In 2011, 2,627 IVF cases from 14 IVF clinics
were recorded in Indonesia, with a success rate of
38.5% (6). According to the Yasmin Clinic Dr. Cipto
MangunkusumoNational General Hospital (RSCM),
318 IVF cycles were recorded in 2013 and 551
cycles in 2014. Participants as much as 39 women
were recorded as poor responders in 2013 and 24
women in 2014 (7, 8).
Response to ovarian stimulation by examining
ovarian reserve is important to determine the
success of ART (9). The poor-responder group is
a group of participants who have ≤ 3 oocytes
after ovarian stimulation (10). In 2011, the Bologna
criteria indicated that a poor responder must meet
two of the three criteria, which include age > 40
yr or presence of risk factors, antral follicle count
(AFC) < 6-8 follicles per ovary or anti-Müllerian
hormone (AMH) level < 0.5-1.1 ng/mL, and a history
of producing ≤ 3 oocytes after ovarian stimulation
(2). However, Poseidon classification is the current
criteria recommended by the European Society
of Human Reproduction and Embryology (ESHRE)
guideline. Ovarian reserve marked by low quantity
of oocytes is associated with the quality of IVF
outcomes. Ovarian reserve refers to the number,
size, and quality of primordial follicles in the ovary
and the reproductive potential of each oocyte (11).
The best parameters to identify ovarian reserve
conditions are age, AMH level, and AFC (12). An
association was observed between AMH level and
the number of follicles in the ovary. A study in
Indonesia has shown that an AMH level of 1.40
µg/mL and AFC at 7 is the cut-off values used to
predict good response and ovarian condition (13).
Ovarian reserve is typically affected by
various factors such as age, body mass
index (BMI), endometriosis, history of ovarian
surgery, chemotherapy, and radiotherapy (14-
16). Participants at 35 yr of age affect the low
number and quality of primordial follicles, thereby
affecting ovarian reserve and infertility (14). In
addition, BMI also affects the ovarian reserves
by changing the metabolism and hormone level
of women (17). Moreover, a history of ovarian
surgery can reduce ovarian reserve due to
vascular injury, infection after surgery, and micro
thromboembolism (14). Endometriosis is the other
factor affecting ovarian reserves particularly in
young participants (18). The association between
decreased ovarian reserve and endometriosis
caused by chronic inflammation that affects
dormant follicles in the ovarian cortex has also
been reported (19).
This study aimed to determine the most
significant factors affecting poor ovarian response
and the severity of the effect on decreased
ovarian reserve based on the Poseidon group
classifications. The first objective of this study
was to find the most significant association
between the six independent variables- that is
age, BMI, endometriosis, endometriosis location,
history of ovarian surgery, and AMH- and poor-
responder participants women. The second goal
was to find some association between each
Poseidon group and three independent variables
as the factors, that is BMI, history of surgery, and
endometriosis.
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2. Materials and Methods
This cross-sectional study was conducted from
January 2013 to June 2017. Data were obtained
by consecutive sampling. Participants data, such
as age, BMI, endometriosis, and history of ovarian
surgery, were obtained from medical records.
Women who had undergone controlled ovarian
stimulation protocol of IVF using gonadotropin,
those who were assessed for ovarian reserve
based on the number of oocytes via ovum pick-up,
and those classified as good and poor responders
were included. However, women with infertility
due to congenital or anatomical abnormality were
excluded from the study.
In this study, participants were divided into
good and poor responder groups based on the
ovarian reserve test; participant with oocyte ≤ 3
was classified as a poor responder. Based on
this, 188 participants with nine (4-47) oocytes were
included in the poor responder group. While, good
responder comprised of two (0-3) oocytes. Then,
based on the Poseidon criteria- which is the criteria
of poor responder risk factor, the poor-responder
participants were classified. The Poseidon criteria
comprised into four groups, as shown in Table
I.
2.1. Antagonist protocol
Gonadotropin injection was started on day 2 or
3 of the period with initial doses between 300 and
375 IU. Meanwhile, GnRH antagonist was injected
0.25 mg daily starting on day 6 of the stimulation
or when the diameter of the leading follicle was
14 mm. Ovulation trigger with rhCG 250 ug was
initiated when at least three follicles reached a
diameter of ≥ 17 mm. Ovum pick-up was done
approximately 36 hr after oocyte maturation which
was triggered with rhCG.
Table I. Classification of Poseidon
Poseidon group Age (yr) AFC (follicle) AMH (ng/ml) The number of oocytes in the previousstimulation
Group 1 < 35 ≥ 5 1.2 Subgroup 1a: <4 oocytesSubgroup 1b: 4-9 oocytes
Group 2 ≥ 35 ≥ 5 1.2 Subgroup 2a: <4 oocytesSubgroup 2b: 4-9 oocytes
Group 3 < 35 < 5 < 1.2 —
Group 4 ≥ 35 < 5 < 1.2 —
Ovarian responses are classified into four groups. Poseidon group 1 and 3 are group of women aged< 35 years, while Poseidon
group 2 and 4 are the group of women aged≥ 35 years. Adopted fromAlviggi C et al, Fertil Steril, 2016 (20), AMH: Anti-mullerian
hormone; AFC: Antral follicle count
2.2. Ethical consideration
This study was approved by the ethics
committee of the Faculty of Medicine
on August 06, 2018 (reference number:
0781/UN2.F1/ETHIC/2018). Informed consent
was obtained from all participants before study
enrollment.
2.3. Statistical analysis
Data were analyzed via bivariate tests using
Chi-square test and Mann-Whitney U-test, and
a multivariate analysis using linear regression
was conducted to assess factors that lead most
to the low ovarian reserve in poor-responder
participants. A p-value < 0.05 was considered
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as statistically significant. Confidence interval
95% (CI 95%) was the benchmark to evaluate the
data. Data were analyzed using the Statistical
Package for the Social Sciences software
version 20.0, SPSS Inc, Chicago, Illinois, USA
(SPSS).
3. Results
3.1. Characteristics of the participants
A total of 749 participants underwent ovarian
stimulation and met the eligibility criteria
from 2013 to 2017. Based on the Poseidon
criteria, 262 (35%) participants were included
in the non-Poseidon group, seven (0.9%)
in the Poseidon 1a group, 64 (8.5%) in the
Poseidon 1b, 30 (4%) in the Poseidon 2a, 113
(15.1%) in the Poseidon 2b, 73 (9.8%) in the
Poseidon 3, and 200 (26.7%) in the Poseidon
group 4.
Table II presents the characteristics of
participants based on ovarian reserve test.
Based on the number of oocytes, 188 (25%)
participants were included in the poor-responder
and 561 (75%) in the good-responder groups.
The age of the poor-responder participants
was 38.5 (25-50) years, primary infertility was
reported in 170 (90.4%) respondents, the average
durations of infertility was 8 yr (range: 1-23),
the average BMI was 23.37 kg/m2, the average
number of oocytes was 2 (0-2), and the average
AMH levels were 0.55 (0.01-4.65). In this study,
a majority of the, that is, 135 (71.8%) participants,
did not have endometriosis. The main location
of endometriosis was in the ovarium in 30
(56.6%) participants. Most participants in both
groups did not have a history of ovarian surgery -
164 (87.2%) participants in the poor-responder
group.
3.2. Relationship between some
factors and poor ovarian response
according to oocyte count
The association between age, BMI,
endometriosis, and history of ovarian surgery
with poor-responder group are presented in
Table III.
It is also shows that age ≥ 35 yr was a
significantly strong risk factor in poor-responder
group. Furthermore, endometriosis was twice
as a higher risk factor for them. However, no
association was observed between the location
of endometriosis and the poor responders
(p = 0.105). A history of ovarian surgery was
significantly 2.3 times higher a risk factor for
poor responders. However, further analysis
using logistic regression, which included AMH
as an additional cofounding factor, showed
that only age (p = 0.004) and AMH level
(p < 0.001) were significantly associated with
the poor-responder group. Meanwhile, BMI,
endometriosis, and history of ovarian surgery
were not significantly associated with the
incidence of poor-response. Table IV shows
the multivariate analysis of each Poseidon group.
Endometriosis was a significant predictor of
classification under Poseidon groups 1 and 4 -
with an odds ratio of 2.5 and 2.7, respectively.
A history of ovarian surgery was a significant
determinant of inclusion in Poseidon groups 2
and 3 (p < 0.05), whereas an increase in BMI
decreased the risk of inclusion in Poseidon group
3.
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Table II. Characteristics of participants
Demographical and clinical characteristics Good-responder group (n = 561) Poor-responder group (n = 188)
Age (yr)* 35 (22-48) 38.5 (25-50)
Infertility **
Primary 302 (53.8) 170 (90.4)
Secondary 259 (46.2) 41 (21.8)
Length of infertility (yr)* 7 (1-23) 8 (1-23)
BMI (kg/m2)* 23.63 (15.63-43.28) 23.37 (15.43-38.87)
Number of oocytes* 9 (4-47) 2 (0-3)
AMH* 2.68 (0.01-34.06) 0.55 (0.01-4.65)
Endometriosis**
Yes 92 (16.4) 53 (28.2)
No 469 (83.6) 135 (71.8)
Location of endometriosis**
Ovarium 67 (72.8) 30 (56.6)
Extra ovarium 10 (10.9) 7 (13.2)
Both 15 (16.3) 16 (30.2)
History of ovarian surgery**
Yes 33 (5.9) 24 (12.4)
No 528 (94.1) 164 (87.2)
Kolmogorov-smirnov test as a benchmark for data abnormality. *Data presented as median range for the abnormally distributed
data; **Data presented as mean for the normally distributed data. BMI: Body mass index; AMH: Anti-mullerian hormone
Table III. Association of age, BMI, endometriosis, and history of ovarian surgery with the poor-responder group
Demographical and clinical characteristics Good-responder
group (n = 561)
Poor-responder
group (n = 188)
p-value OR; 95% CI
Age (yr)*
≥ 35 302 (53.8) 147 (78.2)
< 35 259 (46.2) 41 (21.8)
< 0.001𝑎 3.1 (2.1-4.5)
BMI (kg/m2)** 23.63 (15.63-43.28) 23.37 (15.43-38.87) 0.174
Endometriosis *
Yes 92 (16.4) 53 (28.2)
No 469 (83.6) 135 (71.8)
< 0.001𝑎 2.0 (1.3-2.9)
Location of endometriosis*
Ovarium 67 (72.8) 30 (56.6)
Extra ovarium 10 (10.9) 7 (13.2)
Both 15 (16.3) 16 (30.2)
0.105
History of ovarian surgery*
Yes 33 (5.9) 24 (12.4)
No 528 (94.1) 164 (87.2)
0.002𝑎 2.3 (1.3-4.1)
*Chi-Square test; data presented as n (%). **Mann-Whitney U test; Data presented as Median range, BMI: Body mass index; CI:
Confidence interval; a: Significant p-value
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Table IV. Multinomial regression analysis to predict Poseidon group
BMI History of surgery EndometriosisPoseidon groups
p-value OR (95% CI) p-value OR (95% CI) p-value OR (95% CI)
Group 1 0.45 — 0.808 — 0.013* 2.5 (1.2-5.2)
Group 2 0.304 — 0.007* 4.6 (1.5-13.9) 0.118 —
Group 3 0.024* 0.9 (0.8-0.99) < 0.001* 10.7 (3.4-33.9) 0.208 —
Group 4 0.933 — 0.10 — < 0.001* 2.7 (1.6-4.7)
BMI: Body mass index; CI: Confidence interval; *Significant with multinomial regression analysis used to classify Poseidon group
based on the risk factor
4. Discussion
In this study, an association between age ≥ 35
yr and poor responder was observed. A total of
78.2% participants aged ≥ 35 yr were at 3.1 (2.1-
4.5) times higher risk for poor response than those
aged < 35 yr. Several studies have used age ≥ 40
yr as a predictor of poor response. Whereas, some
have used a cut-off value of 35 yr (Poseidon group)
(14, 21). An increase in the BMI decreased the risk
to be classified under Poseidon group 3. Halawaty
and colleagues showed insignificant difference
between obese and nonobese participants in
terms of age, serum AMH level, serum FSH
level, fasting blood glucose level, 2-h post-prandial
blood glucose level, and AFC (22). Additionally,
an increase in BMI was correlated to polycystic
ovarium syndrome (PCOS) and higher AMH levels.
Some study showed that most obese participants
with PCOS had higher AMH level and metabolic
disruption (23, 24). Therefore, an increase in BMI
decreases the risk of poor response.
In terms of BMI, the poor-responder group had
a higher BMI than the good-responder group.
However, the result was not significantly different
(p > 0.05). The association between obesity and
ovarian reserve remains controversial. A study
showed the negative effects of obesity on ovarian
reverses (25). De Pergola et al explained that
the follicle-stimulating hormone (FSH), luteinizing
hormone (LH), inhibin B, and estradiol levels
in women of reproductive age, who are either
overweight or obese, were lower than those of
women with normal weight in the early follicular
phase due to the inhibitory effect of body mass
on gonadotropin and estradiol production (26).
However, several studies have shown that obesity
is not associated with AFC. Moreover, lower AMH
levels in obese women of reproductive age are
attributed to physiological process and does not
decrease the ovarian reserve (25-27).
In this study, endometriosis was significantly
associated with poor responders (p < 0.001). The
participants with endometriosis were at 2.0 (1.3-2.9)
times higher risk to be a poor responder than those
without. However, no association was observed
between the location of endometriosis and poor
response (p > 0.05). A small study reported that
34 women with endometriosis had lower AMH
levels than those with infertility due to tubal factors
(1.26 vs 2.02 ng/mL; p = 0.004) (28). Dokras
and co-authors founded that inhibin B level was
significantly lower in women with endometriosis
than thosewithout during gonadotropin stimulation
(29). Hwu and colleagues and Uncu and co-
workers also reported that the serum AMH level of
women with endometriosis was significantly lower
than the control group. However, they diagnosed
endometriosis only by ultrasonography (30, 31).
According to the Poseidon criteria, endometriosis
was a significant predictor for Poseidon group 1.
The participants with endometriosis were at 2.5
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times higher risk to be classified under Poseidon
groups 1 and 4 (95% CI: 1.5-5.2). Theoretically,
endometriosis reduces ovarian reserve due to its
inflammatory effects on the ovarian cortex based
on serumAMH levels. The density of ovarian cortex
in women with endometriosis decreases due to the
formation of fibrotic tissues (32). A study showed
that endometriosis cause a decrease in serum
estradiol levels and production of LH-dependent
progesterone (33).
Interestingly, a significant association was
observed between a history of ovarian surgery
and poor response (p < 0.05). Participants with a
history of ovarian surgery were at 2.3 times higher
risk to be poor responder (95% CI: 1.3-4.1). Lind and
colleagues assessed the effect of cyst removal
on ovarian reserve by measuring serum AMH
levels (34). Another study also reported about
a continuous decreased in serum AMH levels
from 2.7 µg/L to 2.0 µg/L at a six-month follow-up
after surgery and to 1.0 µg/L at two-year follow-up
(34). A history of ovarian surgery was a significant
predictor of classification under Poseidon groups
2 and 3. The participants with a history of ovarian
surgery were at 4.6 times higher risk for poor
response (95% CI: 1.5-13.9) than those without.
The results of this study were similar to those of
other studies showing a continuous decrease in
serum AMH levels from 2.7 µg/L to 2.0 µg/L at a
six-month follow-up after surgery and to 1.0 µg/L at
a two-year follow-up (34).
5. Conclusion
Significant differenceswere observed in terms of
age, endometriosis, and history of ovarian surgery
in the poor-responder group. Endometriosis was
a significant predictor of classification under
Poseidon groups 1 and 4, and a history of ovarian
surgery was a significant predictor of classification
under Poseidon groups 2 and 3. Furthermore, BMI
was a significant predictor of classification under
Poseidon group 3. Age, BMI, endometriosis, and
history of ovarian surgery were associated with
ovarian reserve in the poor-responder group.
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